Adverse events (any) · people with dementia
Discontinuing cholinesterase inhibitor showed no clear difference in adverse events (any) compared with continued cholinesterase inhibitor (low certainty).
1 finding from 1 review
SAEs · people with dementia
Discontinuing cholinesterase inhibitor showed no clear difference in serious adverse events (SAEs) compared with continued cholinesterase inhibitor (low certainty).
1 finding from 1 review
Deaths · people with dementia
Discontinuing cholinesterase inhibitor showed no clear difference in deaths compared with continued cholinesterase inhibitor (low certainty).
1 finding from 1 review
Functional status, short‐term · people with dementia
1 finding from 1 review
Change in NPI · people with dementia
2 findings from 1 review
Change in MMSE · patients withdementia
1 finding from 1 review
Functional ability · patients withdementia
1 finding from 1 review
Change in NPI · patients withdementia
1 finding from 1 review
Functional status (change from baseline, long term) BADLS · people with dementia
1 finding from 1 review
Intervention not reported
Clinical Global (CIBIC+) · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review
Intervention not reported
Clinical Global: (CIBIC+) · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Cognitive function: ADAS‐Cog 70‐point scale · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Performance on ADL (NOSGER self care subscale) Subscale 5 points · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Behaviour: NOSGER disturbing behaviour subscale Subscale 5 points · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Binary outcomes · vascular dementia, mild‐to‐moderate severity
The review found no eligible studies for this question.
1 finding from 1 review
Memantine for dementia 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause discontinuation · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Number suffering at least one adverse event · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Number suffering at least one serious adverse event · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Number suffering agitation as an adverse event · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Cognitive Function (SIB) · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review